SUN PHARMA ADVANCED RESEARCH COMPANY
Back to All Ratios
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Price to Cash Earnings (PCE) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| PCE(x) | 2.38 | -14.55 | -32.04 | -27.62 |
What is the latest Price to Cash Earnings (PCE) ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Price to Cash Earnings (PCE) |
|---|---|
| Mar2026 | 2.38 |
| Mar2025 | -14.55 |
| Mar2024 | -32.04 |
| Mar2023 | -27.62 |
How is Price to Cash Earnings (PCE) of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Price to Cash Earnings (PCE) | % Change | |
|---|---|---|---|
| Mar2026 | 2.38 | Positive | |
| Mar2025 | -14.55 | Negative | |
| Mar2024 | -32.04 | Negative | |
| Mar2023 | -27.62 | - | |
Other Financial Ratios of SUN PHARMA ADVANCED RESEARCH COMPANY
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Price to Cash Earnings (PCE) ratio of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹7,022.2 Cr | -4.9% | -4.7% | 33% | Stock Analytics | |
| PRIME FOCUS | ₹22,448.3 Cr | 1.7% | 35% | 67% | Stock Analytics | |
| SAGILITY | ₹18,940.7 Cr | -2.1% | 1% | -8.1% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹16,413.2 Cr | -2.6% | -8.2% | -39.8% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹14,639.4 Cr | -0.9% | -3.8% | -11.6% | Stock Analytics | |
| INDEGENE | ₹11,870.4 Cr | -3.2% | -6.5% | -15.5% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -4.9% |
-4.7% |
33% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses